摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 2-azido-3-(2-bromophenyl)prop-2-enoate | 220448-44-2

中文名称
——
中文别名
——
英文名称
Methyl 2-azido-3-(2-bromophenyl)prop-2-enoate
英文别名
methyl 2-azido-3-(2-bromophenyl)prop-2-enoate
Methyl 2-azido-3-(2-bromophenyl)prop-2-enoate化学式
CAS
220448-44-2
化学式
C10H8BrN3O2
mdl
——
分子量
282.096
InChiKey
CINPLCMEILSUTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    40.7
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    Methyl 2-azido-3-(2-bromophenyl)prop-2-enoate5,5-dimethyl-1,3-cyclohexadiene 为溶剂, 反应 2.0h, 以74%的产率得到4-溴吲哚-2-甲酸甲酯
    参考文献:
    名称:
    作为Lamellarin D类似物的chromeno [3,4- b ]吲哚的合成:一种新型DYRK1A抑制剂
    摘要:
    开发了取代的chromeno [3,4- b ]吲哚文库作为lamellarin等位基因。在涉及C的四步路径序列之后,由吲哚完成合成-3碘化,Suzuki交叉偶联反应和一锅脱保护/内酯化步骤。测试了二十种最终化合物以确定它们对拓扑异构酶I和激酶(Lamellarins的两种主要生物学活性)的活性。一种新合成的衍生物显示出强大的拓扑异构酶活性,可与参比化合物(例如喜树碱和lamellarin)相比,但激酶抑制作用较弱。其他两种先导化合物被鉴定为新的纳摩尔DYRK1A抑制剂,其他几种药物影响亚微摩尔范围内的激酶。这些结果将使我们能够使用chromeno [3,4- b ]吲哚作为药效团来开发有效治疗涉及DYRK1A的神经系统或肿瘤性疾病的方法。
    DOI:
    10.1016/j.ejmech.2012.01.040
  • 作为产物:
    参考文献:
    名称:
    Extending the versatility of the Hemetsberger–Knittel indole synthesis through microwave and flow chemistry
    摘要:
    Microwave, flow and combination methodologies have been applied to the synthesis of a number of substituted indoles. Based on the Hemetsberger-Knittel (HK) process, modifications allow formation of products rapidly and in high yield. Adapting the methodology allows formation of 2-unsubstituted indoles and derivatives, and a route to analogs of the antitumor agent PLX-4032 is demonstrated. The utility of the HK substrates is further demonstrated through bioconjugation and subsequent ring closure and via Huisgen type [3+2] cycloaddition chemistry, allowing formation of peptide adducts which can be subsequently labeled with fluorine tags. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.01.066
点击查看最新优质反应信息

文献信息

  • 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
    申请人:Sanofi-Synthelabo
    公开号:US06262045B1
    公开(公告)日:2001-07-17
    Compounds of general formula (I) in which X represents a hydrogen or halogen atom or a methyl, methoxy or phenylmethoxy group, Y represents a hydrogen atom, 1 or 2 halogen atoms or a hydroxyl, methoxy, nitro or methyl group, R1 represents a hydrogen atom or a (C1-C4)alkyl group, R2 and R3 each represent a hydrogen atom, a (C1-C4)alkyl group or a phenylmethyl group or else R2 and R3 form, with the nitrogen atom which carries them, an azetidinyl, pyrrolidinyl, 3-ethoxypyrrolidinyl, piperidinyl, morpholinyl, 4-methylpiperazinyl or 1,3-thiazolidinyl group. Application in therapeutics.
    通式(I)的化合物中,X代表氢或卤素原子,或甲基,甲氧基或苯甲氧基基团,Y代表氢原子,1或2个卤素原子或羟基,甲氧基,硝基或甲基基团,R1代表氢原子或(C1-C4)烷基,R2和R3各代表氢原子,(C1-C4)烷基或苯甲基基团,或者R2和R3与它们所携带的氮原子形成氮杂环,包括氮杂丙环,吡咯烷环,3-乙氧基吡咯烷环,哌啶环,吗啉环,4-甲基哌嗪环或1,3-噻唑烷环。在治疗学中的应用。
  • Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class
    作者:Cleopatra Neagoie、Emeline Vedrenne、Frédéric Buron、Jean-Yves Mérour、Sorin Rosca、Stéphane Bourg、Olivier Lozach、Laurent Meijer、Brigitte Baldeyrou、Amelie Lansiaux、Sylvain Routier
    DOI:10.1016/j.ejmech.2012.01.040
    日期:2012.3
    developed as Lamellarin isosters. Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonisation step. Twenty final compounds were tested in order to determine their activity against topoisomerase I and kinases, the two major biological activities of Lamellarins. One newly synthesized derivative exhibited
    开发了取代的chromeno [3,4- b ]吲哚文库作为lamellarin等位基因。在涉及C的四步路径序列之后,由吲哚完成合成-3碘化,Suzuki交叉偶联反应和一锅脱保护/内酯化步骤。测试了二十种最终化合物以确定它们对拓扑异构酶I和激酶(Lamellarins的两种主要生物学活性)的活性。一种新合成的衍生物显示出强大的拓扑异构酶活性,可与参比化合物(例如喜树碱和lamellarin)相比,但激酶抑制作用较弱。其他两种先导化合物被鉴定为新的纳摩尔DYRK1A抑制剂,其他几种药物影响亚微摩尔范围内的激酶。这些结果将使我们能够使用chromeno [3,4- b ]吲哚作为药效团来开发有效治疗涉及DYRK1A的神经系统或肿瘤性疾病的方法。
  • Extending the versatility of the Hemetsberger–Knittel indole synthesis through microwave and flow chemistry
    作者:Nadeesha Ranasinghe、Graham B. Jones
    DOI:10.1016/j.bmcl.2013.01.066
    日期:2013.3
    Microwave, flow and combination methodologies have been applied to the synthesis of a number of substituted indoles. Based on the Hemetsberger-Knittel (HK) process, modifications allow formation of products rapidly and in high yield. Adapting the methodology allows formation of 2-unsubstituted indoles and derivatives, and a route to analogs of the antitumor agent PLX-4032 is demonstrated. The utility of the HK substrates is further demonstrated through bioconjugation and subsequent ring closure and via Huisgen type [3+2] cycloaddition chemistry, allowing formation of peptide adducts which can be subsequently labeled with fluorine tags. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多